admin

Remedium Technologies Inc., a medical device company developing innovative products to control severe hemorrhaging, was awarded a $500,000 Small Business Innovation Research (SBIR) grant from the National Science Foundation to test the company’s sprayable foam for rapidly halting traumatic bleeding, company officials announce today.

In collaboration with Massachusetts General Hospital and the University of Maryland, Remedium will complete pre-clinical trials to evaluate the safety and efficacy of Hemogrip(TM) Foam in controlling non-compressible hemorrhaging, i.e., bleeding not accessible to direct pressure. Hemogrip(TM) is a high-pressure, sprayable foam that can expand into an injured body cavity, adhere to tissue and stop hemorrhaging within minutes during the expansion process. There are currently no hemostatic products available for treatment of non-compressible bleeds, which account for 85 percent of hemorrhage-related deaths.

The U.S. market for remote patient monitoring, valued at $104.5 million in 2012, is forecasted to reach $296.5 million by 2019, a compound annual growth rate of 16 percent, according to a new report from GBI Research.

Chronic diseases represent an overwhelming burden for healthcare systems in developed countries, due to increasingly elderly populations, and a clear need exists for remote patient monitoring to help lift the load off stretched healthcare resources, according to the report Remote Patient Monitoring Market to 2019 – Potential to Reduce Healthcare Cost Burden and Improve Quality of Care to Drive Future Growth.

With nearly half a billion dollars raised in venture capital funding for health information technology, the first three months of 2013 represented a “record quarter,” according to Mercom Capital Group.

Some $493 million was raised industry-wide, according to Mercom’s 2013 Healthcare IT Funding and M&A Report, in twice as many deals as the previous quarter (104, up from 51). There were nearly four times as many early stage deals – 42, up from 14 – compared to the fourth quarter of 2012.

The University of Maryland, Baltimore County and Northrop Grumman Corp. last month expanded their Cync cybersecurity  program with three new companies, including the program’s first international one. The three firms joined the five companies currently at bwtech@UMBC Research and Technology Park in Catonsville.

Two Baltimore companies took top honors in the state’s first InvestMaryland Challenge.

GrayBug, which is developing drug delivery technology; and RedOwl Analytics, a software company, were the winners of the startup business competition’s life science and information technology categories. An LED lighting company in Cecil County, i-Lighting, won the contest’s category for general industry. Some 260 startups from 26 states, including Maryland, threw their hats in the ring.

Eight years of work, thousands of researchers around the world, $1 billion spent — and finally it was done. On April 14, 2003, a decade ago this week, scientists announced that they had completed the Human Genome Project, compiling a list of the three billion letters of genetic code that make up what they considered to be a sort of everyperson’s DNA.